What's new

Human medicines European public assessment report (EPAR): Fabhalta, Iptacopan, Date of authorisation: 17/05/2024, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Fabhalta, Iptacopan, Date of authorisation: 17/05/2024, Revision: 3, Status: Authorised

Feb 20, 2025 - 16:30
 0
Human medicines European public assessment report (EPAR): Fabhalta, Iptacopan, Date of authorisation: 17/05/2024, Revision: 3, Status: Authorised
Human medicines European public assessment report (EPAR): Fabhalta, Iptacopan, Date of authorisation: 17/05/2024, Revision: 3, Status: Authorised
Read More

Tags:

Previous Article

SpaceX Has Already Infiltrated The Agency That Regulates It

Next Article

The AI energy challenge is coming to a head

Related Posts

Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 51, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 10, 2025  0

Regulatory Procedure Management (RPM) for the Product L...

Mar 3, 2025  0

PSUSA/00010184/202406

PSUSA/00010184/202406

Feb 13, 2025  0